Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas of the healthcare value chain.
Tag: Real World Data
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working practices to access the database and ongoing SNDS developments, explained the similarities and differences between SNDS and other claims databases, used case studies to illustrate its strengths and opportunities, and provided stakeholder perspectives on current and potential benefits to patients, … Continued
Key Trends in U.S. Specialty Pharmacy
The Escalating U.S. Policy Environment
Innovative Financing for Novel Therapies
The Rise of Cost Effectiveness Considerations in the US
SNDS Brochure
Certara Launches BaseCase Data Manager to Enhance Value-based Customer Presentations
Data Manager allows clients to include large, real-world datasets in their customer presentations in an efficient, compliant manner
Trends for Market Access, HEOR, and Real World Evidence
This blog reviews trends for using health economics and outcomes research and real-world evidence to evaluate the value of medicines and health technologies.
Real World Evidence Marches Forward in Drug Development
The end of 2018 ushered in a flurry of new regulatory guidance and sponsor enthusiasm on real-world evidence (RWE) and its adoption in the drug development process. While the collection of real-world data (RWD) and use of RWE is not new, they are now poised to have a profound impact on our industry. Today, it … Continued
